Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250053 · ClinicalTrials.gov registry record · NA
Exercise and Colon Cancer
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02250053 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 44 participants.
The verdict
NCT02250053, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.
Interventions
- OTHER Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02250053
The ClinicalTrials.gov registry entry for NCT02250053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT02250053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02250053 about?
NCT02250053 is a clinical study titled "Exercise and Colon Cancer". Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aim...
What is the current status of trial NCT02250053?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-12. Estimated completion is 2016-01-15.
What interventions are being tested in trial NCT02250053?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT02250053?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.